Compare WVE & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | CCU |
|---|---|---|
| Founded | 2012 | 1850 |
| Country | Singapore | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2015 | 2001 |
| Metric | WVE | CCU |
|---|---|---|
| Price | $7.26 | $11.64 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 16 | 2 |
| Target Price | ★ $30.25 | $12.00 |
| AVG Volume (30 Days) | ★ 5.4M | 241.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $0.34 | $9.69 |
| Revenue Next Year | $83.30 | $6.15 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.02 | $10.71 |
| 52 Week High | $21.73 | $15.75 |
| Indicator | WVE | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 30.10 | 45.28 |
| Support Level | $6.94 | $11.51 |
| Resistance Level | $8.29 | $12.38 |
| Average True Range (ATR) | 0.75 | 0.36 |
| MACD | -0.50 | 0.12 |
| Stochastic Oscillator | 26.85 | 81.07 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.